Wide-moat stocks have performed better than the market overall as investors sought stability in a fully valued market.
Plus, a 'patient' Fed sparks a rally, FedEx under-delivers, and more.
Plus, more muddling for Europe, a pricey purchase for Merck, and U.S. retail registers ring.
Plus, no QE present yet for the eurozone, auto sales rev, and Barnes & Noble reclaims its Nook.
A closer look at Berkshire's deal for Duracell, what net neutrality may mean for Internet service providers, and more.
Our take on this week's deals. Plus, the Fed sticks to its course, and home-improvement retail results paint hopeful signs for housing.
Welcome to Morningstar, where we're dedicated to helping you understand and analyze stocks, funds, and your own portfolio. We have a staff of 170 analysts covering more than 950 stocks , 1,150 mutual funds , and 300 ETFs ; some of the best investment tools on the Internet; and an unrivaled ...
Central Bank recipes, leftover housing disappointments, and full valuations may still cause indigestion for investors, says Morningstar markets editor Jeremy Glaser.
Why this week's GDP wasn't quite as good as it looked. Plus: Hawkish hints from the Fed and earnings hits and misses.
Near-term headwinds shouldn't derail Priceline's prospects. Plus, a midterm election reality check for investors, and more.